Get the Stockscreener App
15.84
1.49%
-0.24
Adma Biologics Inc stock is traded at $15.84, with a volume of 2.00M.
It is down -1.49% in the last 24 hours and down -1.98% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$16.08
Open:
$16.22
24h Volume:
2.00M
Relative Volume:
0.87
Market Cap:
$3.74B
Revenue:
$382.81M
Net Income/Loss:
$68.13M
P/E Ratio:
56.57
EPS:
0.28
Net Cash Flow:
$78.82M
1W Performance:
-0.38%
1M Performance:
-1.98%
6M Performance:
-11.21%
1Y Performance:
+205.79%
1-Day Range:
$15.73
$16.40
1-Week Range:
$15.60
$16.67
52-Week Range:
$5.08
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
15.84 | 3.74B | 382.81M | 68.13M | 78.82M | 0.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
ADMA Biologics announces executive and director compensation changes By Investing.com - Investing.com Nigeria
Adma Biologics (ADMA) Stock Moves -1.49%: What You Should Know - MSN
ADMA Biologics announces executive and director compensation changes - Investing.com
(ADMA) Technical Pivots with Risk Controls - Stock Traders Daily
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts - MSN
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
ADMA Biologics Gears Up to Report Q4 Earnings: What's in the Cards? - MSN
Allspring Global Investments Holdings LLC Buys 2,613,482 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Legato Capital Management LLC Reduces Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
SG Americas Securities LLC Cuts Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Nkcfo LLC Makes New Investment in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Empowered Funds LLC Invests $5.68 Million in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics (ADMA) Stock Moves -0.25%: What You Should Know - Nasdaq
Pharma Stock Poised to Bounce Off Support - Yahoo Finance
When the Price of (ADMA) Talks, People Listen - Stock Traders Daily
ADMA Loses 8.9% in a Month: How Should You Play the Stock? - MSN
Adma Biologics (ADMA) Advances But Underperforms Market: Key Facts - MSN
ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Holdings Lifted by Calamos Advisors LLC - MarketBeat
ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add (NASDAQ:ADMA) - Seeking Alpha
Exploring Three High Growth Tech Stocks in the United States - Simply Wall St
Janney Montgomery Scott LLC Sells 6,603 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Pacer Advisors Inc. Sells 866 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - ETF Daily News
Engaging In Insider Activity, Kaitlin M. Kestenberg-Messina At ADMA Biologics Exercises Options Worth $28K - Benzinga
Will Weakness in ADMA Biologics, Inc.'s (NASDAQ:ADMA) Stock Prove Temporary Given Strong Fundamentals? - Simply Wall St
Pacer Advisors Inc. Has $656,000 Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note - Nasdaq
Short Interest in ADMA Biologics, Inc. (NASDAQ:ADMA) Increases By 11.8% - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Bought by Nisa Investment Advisors LLC - Defense World
Jim Cramer on ADMA Biologics, Inc. (ADMA): ‘I Would Wait For It To Come Down Before I Would Pull The Trigger’ - Insider Monkey
8 Stocks on Jim Cramer’s Radar - Insider Monkey
Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business' - Benzinga
Where are the Opportunities in (ADMA) - Stock Traders Daily
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
ADMA STOCK DROP ALERT: ADMA Biologics, Inc. Stock Drops over 20%; BFA Law Initiates Securities Fraud Investigation and Urges Investors with Losses to Contact the Firm (Nasdaq:ADMA) - ACCESS Newswire
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Inspire Investing LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics Inc (ADMA) And Encourages Investors to Reach Out - ACCESS Newswire
Veracity Capital LLC Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics to acquire certain assets from Biotest Pharmaceuticals Corp - Reuters
Peering Into ADMA Biologics's Recent Short Interest - Benzinga
Brokers Set Expectations for ADMA Biologics FY2025 Earnings - MarketBeat
Perpetual Ltd Acquires Shares of 3,632,677 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock? - MSN
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adma Biologics Inc Stock (ADMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ELMS STEVE | Director |
Nov 27 '24 |
Option Exercise |
10.80 |
9,000 |
97,200 |
2,124,671 |
| Tade Brad L. | CFO and Treasurer |
Nov 22 '24 |
Sale |
21.15 |
15,000 |
317,250 |
199,433 |
| Grossman Adam S | President and CEO |
Nov 22 '24 |
Sale |
21.10 |
48,967 |
1,033,204 |
1,989,007 |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):